Keyphrases
Tumor Promoter
100%
FasL
100%
Cancer Cells
50%
Specific Intent
50%
Liver Cancer
37%
Ovarian Cancer
37%
Cancer Formation
25%
Energy Metabolism
25%
Tumor Cells
25%
In Cancer
25%
Cancer Patients
25%
Fas-mediated Apoptosis
12%
JNK1
12%
CD95
12%
Tumorigenic Activities
12%
Tumor Evasion
12%
Non-apoptotic Functions
12%
Tissue Cells
12%
Basal Activity
12%
Optimal Growth
12%
Constitutive Behavior
12%
Fas Receptor
12%
Soluble Fas
12%
Cancer Progression
12%
Non-apoptotic Signaling
12%
Cancer Cell Survival
12%
Apoptosis-inducing Activity
12%
Activator protein-1 (AP-1)
12%
Cancer Growth
12%
Public Health
12%
Clinically Significant
12%
Apoptosis Resistance
12%
Highly Sensitive
12%
Tissue Homeostasis
12%
Tumor
12%
Apoptosis Induction
12%
Death Receptor
12%
Immune System
12%
Apoptosis
12%
Human Cancer
12%
Therapy Resistance
12%
Preclinical Animal Models
12%
Mouse Model
12%
Cancer Treatment
12%
Tumor-promoting
12%
Medicine and Dentistry
Tumor Promoter
100%
Malignant Neoplasm
100%
Programmed Cell Death
100%
Cancer Cell
100%
Ovarian Cancer
60%
Liver Cancer
60%
Neoplasm
60%
Tumor Cell
40%
Energy Metabolism
40%
Death Receptor
20%
Cancer Treatment
20%
In Vitro
20%
Cancer Growth
20%
Therapy Resistance
20%
Tumor Necrosis Factor Receptor Superfamily Member 6
20%
Receptor
20%
Carcinogenic Activity
20%
Cell Survival
20%
Homeostasis
20%
Immune System
20%
Cancer
20%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Promoter
100%
Malignant Neoplasm
100%
Neoplasm
45%
Liver Cancer
27%
Ovary Cancer
27%
Mouse Model
18%
Elimination
9%
Receptor
9%
Cancer Growth
9%
Tumor Necrosis Factor Receptor Superfamily Member 6
9%
Death Receptor
9%
Therapy Resistance
9%